Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease
โ Scribed by Alan M. Mellow; Trey Sunderland; Robert M. Cohen; Brian A. Lawlor; James L. Hill; Paul A. Newhouse; Martin R. Cohen; Dennis L. Murphy
- Publisher
- Springer
- Year
- 1989
- Tongue
- English
- Weight
- 589 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thyrotropin-releasing hormone (TRH) has been reported to have behavioural effects in man. The current study compared TRH to d-amphetamine and placebo in normal humans. While a number of d-Amp effects were noted, TRH was not significantly different from placebo. K L Y Wmw-TRH, d-amphetamine, stimula
Thirteen drug-free and not severely affected patients with idiopathic Parkinson's disease underwent an insulin-hypoglycaemia test, a TRH test and a levodopa test. The responses of growth hormone, prolactin, cortisol and thyrotropin were measured, and retested under stable therapy with levodopa and b
Acute fulminant hepatitis was induced in 55 healthy adult male rabbits with the potent hepatotoxin galactosamine hydrochloride (3.75 mmoles per kg i.v.). Control rabbits (n = 27) were divided into three groups: Group I (n = 10) underwent sham surgery for placement of an indwelling central venous cat
Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral L